Detalles del proyecto
Descripción
Our vision is to preclinically developed a novel, first-in-class, therapy using aptamer-based Lysosome Targeted
Chimeras (LYTACs) to heal diabetic foot ulcers (DFUs). These LYTACs targets IL-1β and collagenases MMP-
9 and MMP-2 for degradation, all of them proteins that play key role in impaired healing in diabetic wounds.
Chimeras (LYTACs) to heal diabetic foot ulcers (DFUs). These LYTACs targets IL-1β and collagenases MMP-
9 and MMP-2 for degradation, all of them proteins that play key role in impaired healing in diabetic wounds.
| Estado | Activo |
|---|---|
| Fecha de inicio/Fecha fin | 1/04/23 → 31/03/26 |
Huella digital
Explore los temas de investigación que se abordan en este proyecto. Estas etiquetas se generan con base en las adjudicaciones/concesiones subyacentes. Juntos, forma una huella digital única.